Hipra India Private Limited

Hipra India Private Limited - healthcare in Pune City, Maharashtra, India. FY 2026 financials and compliance.
CIN U85100PN2012PTC142264 Incorporated 14 February 2012 ROC Pune HQ Pune City, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹38.24 Cr
▲ 40.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹29.36 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
22
Latest available

About Hipra India Private Limited

Data last updated: 27 December 2025

Hipra India Private Limited is a private limited company based in Pune City, Maharashtra, India, a subsidiary of Laboratorios Hipra Sa. It specialises in medical equipment retail and distribution, a part of the broader healthcare sector. Incorporated on 14 February 2012, the company has been in operation for over 14 years.

Registered with ROC Pune under CIN U85100PN2012PTC142264.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.36 Cr. It is led by directors including Elia Torroella Busquets and Jameer Daulat Patel.

Last AGM: 15 September 2025. Financial statements filed for year ended 31 March 2025. Office: Pune City, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹38.24 Cr, a growth of 40% compared to the previous year.

The company has a workforce of approximately 22 employees as per the latest available data. It operates as a subsidiary of Laboratorios Hipra Sa.

The company is associated with 1 brand - Hipra.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hipra.com.

Company Details of Hipra India Private Limited
CIN U85100PN2012PTC142264
Registration Number 142264
Incorporation Date 14 February 2012
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Laboratorios Hipra Sa
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Office No 609 A And 609 B, S. No. 23P 6Th Floor Nandan Probiz, Pune City, Maharashtra, India – 411045
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Company report
Hipra India Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Hipra India Private Limited report

Financials, compliance, directors, charges, ownership and filings for Hipra India Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Hipra India Private Limited

Hipra India Private Limited operates one associated brand: HIPRA. These brands represent Hipra India Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Vaccines and diagnostic kits for animal diseases are developed. hipra.com

Competitors & Alternatives of Hipra India Private Limited

Brands and companies operating in the same space as Hipra India Private Limited include Ethris, ExeVir Bio, Alchemab and 4 more.

Competitor Description Location Founded
Ethris Ethris mRNA therapeutics for infectious diseases are developed using proprietary platforms. Planegg, Germany, Germany 2009
ExeVir Bio ExeVir Bio Provider of antibody-based therapies to monitor viral infections Ghent, Belgium, Belgium 2020
Alchemab Alchemab Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases London, United Kingdom, United Kingdom 2019
Pardes Biosciences Pardes Biosciences Therapeutics for pandemic diseases including SARS-CoV-2 are developed. Berkeley, United States, United States 2020
Vaxxinity Vaxxinity Vaccines for neurological disorders and infectious diseases are developed. Dallas, United States, United States 2019
Inimmune Inimmune Integrated clinical developmental services to treat food allergy, allergic rhinitis, and auto-immune disorders Missoula, United States, United States 2016
Providence Therapeutics Providence Therapeutics mRNA-based therapeutics for cancer and COVID-19 are developed. Calgary, Canada, Canada 2015

Business Activity of Hipra India Private Limited

Hipra India Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Hipra India Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Hipra India Private Limited

Hipra India Private Limited is audited by UDYEN JAIN AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
UDYEN JAIN AND ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Hipra India Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hipra India Private Limited

Hipra India Private Limited is currently managed by 7 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Elia Torroella Busquets Director 25 Nov 2013 12 Years 8 Months Current
Jameer Daulat Patel Director 24 Apr 2014 12 Years 3 Months Current
Maria Del Mar Nogareda Estivill Director 14 Feb 2012 14 Years 5 Months Current
David Nogareda Estivill Director 14 Feb 2012 14 Years 5 Months Current
Carlos Montanes Estupina Director 14 Feb 2012 14 Years 5 Months Current
David Caballero Tomas Director 07 Jul 2025 1 Years 0 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Hipra India Private Limited FY 2025 filings available

Hipra India Private Limited reported revenue of ₹38.24 Cr (up 40.00% YoY) for FY 2025.

Revenue · FY 2025
₹38.24 Cr ▲ 40.00%
Premium access

Ten-year financial statements for Hipra India Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Hipra India Private Limited

Premium access

Shareholding and ownership data for Hipra India Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Hipra India Private Limited

Hipra India Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Hipra India Private Limited

Hipra India Private Limited has a workforce of 22 employees as of Apr 06, 2024.

Employee count
22
Active EPFO establishments
1
Employee growth
10%
Premium access

Employee and EPFO history for Hipra India Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Hipra India Private Limited

Premium access

GST registrations and filing compliance for Hipra India Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Hipra India Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Hipra India Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hipra India Private Limited

Premium access

MSME payment history for Hipra India Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hipra India Private Limited

Premium access

Corporate group structure for Hipra India Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hipra India Private Limited

Premium access

MCA filings and documents for Hipra India Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Hipra India Private Limited

Activity
15 Sep 2025
Hipra India Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Directors
07 Jul 2025
David Caballero Tomas was appointed as a Director on 07 Jul 2025 & has been associated with this company since 1 year 20 days.
Directors
07 Jul 2025
Peter Cyriel A Saey was appointed as a Director on 07 Jul 2025 & has been associated with this company since 1 year 20 days.
Activity
31 Mar 2025
Hipra India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Directors
25 Jun 2024
Ankita Saraiya was appointed as a Company Secretary on 25 Jun 2024 & has been associated with this company since 2 years 1 month.
Directors
24 Apr 2014
Jameer Daulat Patel was appointed as a Director on 24 Apr 2014 & has been associated with this company since 12 years 3 months.

Frequently Asked Questions about Hipra India Private Limited

Hipra India Private Limited is an active private limited company in the healthcare sector based in Pune City, Maharashtra, India. It was incorporated on 14 February 2012 (14+ years old) and is registered under CIN U85100PN2012PTC142264. The company has 22 employees.

Hipra India Private Limited reported revenue of ₹38.24 Cr for FY 2025 (up 40.00% YoY).

The current directors of Hipra India Private Limited are:

The primary industry of Hipra India Private Limited is healthcare. The company specifically operates in medical equipment retail and distribution. The company is currently active in this sector.

Hipra India Private Limited can be reached at the registered office: Office No 609 A And 609 B, S. No. 23P 6Th Floor Nandan Probiz, Pune City, Maharashtra, India – 411045, or through the website hipra.com.

The authorised capital is ₹30 Cr, and the paid-up capital is ₹29.36 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available